Role of antibody and use of respiratory syncytial virus (RSV) immune globulin to prevent severe RSV disease in high-risk children (Q40746079)

23 September 2017

1 reference

title

Role of antibody and use of respiratory syncytial virus (RSV) immune globulin to prevent severe RSV disease in high-risk children (English)

1 reference

23 September 2017

Groothuis JR

1

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 May 1994

1 reference

The Journal of Pediatrics

23 September 2017

published in

1 reference

23 September 2017

volume

124

1 reference

23 September 2017

issue

5 Pt 2

1 reference

23 September 2017

page(s)

S28-32

1 reference

Epidemiology of respiratory syncytial virus infection in Washington, D.C. 3. Composite analysis of eleven consecutive yearly epidemics

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Epidemiology of acute lower respiratory disease in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Respiratory syncytial virus in infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Respiratory syncytial virus infection in north-east England

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

CLINICAL SIGNIFICANCE OF RESPIRATORY SYNCYTIAL VIRUS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Studies on the role of viruses, bacteria, and M. pneumoniae as causes of lower respiratory tract infections in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Epidemiology of viral and mycoplasmal agents associated with childhood lower respiratory illness in a civilian population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

The epidemiology of acute respiratory tract infection in young children: comparison of findings from several developing countries. Coordinated Data Group of BOSTID Researchers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Apnea associated with respiratory syncytial virus infection in young infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Role of respiratory syncytial virus in early hospitalizations for respiratory distress of young infants with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Respiratory syncytial viral infection in infants with congenital heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Respiratory syncytial viral infection in children with compromised immune function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Respiratory syncytial virus infection in human immunodeficiency virus-infected children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Respiratory-syncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Respiratory syncytial and other viruses associated with respiratory disease in infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Respiratory syncytial virus in early infancy. Circulating antibody and the severity of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Maternal antibody and respiratory syncytial virus infection in infancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Antibodies to respiratory syncytial virus polypeptides and their significance in human infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

The etiology of acute respiratory infections. 3. The role of viruses and bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

7 January 2021

Mechanisms of immunity to respiratory syncytial virus in cotton rats

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

7 January 2021

Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

7 January 2021

Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2894%2970188-1

7 January 2021

10.1016/S0022-3476(94)70188-1

Identifiers

DOI

1 reference

23 September 2017

1 reference